{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:19Z","timestamp":1792098559253,"version":"4.4.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00260","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T04:58:20Z","timestamp":1588049900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The Effects of Different Calcium Channel Blockers on Aldosterone-Producing Adenoma Cells"],"prefix":"10.3389","volume":"11","author":[{"given":"Fen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"E1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"\u00c5kerstr\u00f6m","year":"2012","journal-title":"PLoS ONE"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/TACG.S45620","article-title":"Overview of the genetic determinants of primary aldosteronism","volume":"7","author":"Al-Salameh","year":"2014","journal-title":"Appl Clin Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"B7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/apha.12832","article-title":"Of channels and pumps: different ways to boost the aldosterone","volume":"220","author":"Bandulik","year":"2017","journal-title":"Acta Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1210\/en.2016-1170","article-title":"CACNA1H(M1549V) mutant calcium channel causes autonomous aldosterone production in HAC15 cells and is inhibited by mibefradil","volume":"157","author":"Reimer","year":"2016","journal-title":"Endocrinology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24697","DOI":"10.1038\/srep24697","article-title":"Regulation of aldosterone secretion by Cav1","volume":"6","author":"Xie","year":"2016","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1210\/jc.2016-1504","article-title":"A novel phenotype of familial hyperaldosteronism type III: concurrence of aldosteronism and Cushing's Syndrome","volume":"101","author":"Tong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jsbmb.2014.08.012","article-title":"Voltage-gated calcium channels in the human adrenal and primary aldosteronism","volume":"144","author":"Felizola","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"Perez-Reyes","year":"2003","journal-title":"Physiol Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1345\/aph.17356","article-title":"Mibefradil withdrawn from the market","volume":"32","author":"Billups","year":"1998","journal-title":"Ann Pharmacother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion_ a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.ph.50.030188.002205","article-title":"Regulation of aldosterone secretion","volume":"50","author":"Quinn","year":"1988","journal-title":"Ann Rev Physiol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1681\/ASN.V41111","article-title":"Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism","volume":"4","author":"Cook","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0303-7207(01)00384-7","article-title":"Role of membrane depolarization and T-type Ca2+ channels in angiotensin II and K+ stimulated aldosterone secretion","author":"Lotshaw","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3403292","DOI":"10.1155\/2016\/3403292","article-title":"Interaction between angiotensin II, and Insulin\/IGF-1 exerted a synergistic stimulatory effect on ERK1\/2 activation in adrenocortical carcinoma H295R cells","volume":"2016","author":"Tong","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/cphy.c130037","article-title":"Regulation of aldosterone synthesis and secretion","volume":"4","author":"Bollag","year":"2014","journal-title":"Compr Physiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00260\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T11:44:07Z","timestamp":1666439047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00260\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":22,"alternative-id":["10.3389\/fendo.2020.00260"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00260","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"article-number":"260"}}